Semaglutide can lead to an average of 16.9% of body weight loss in about one year. Semaglutide is an effective medication for obesity treatment with average losses of 9.6–17.4% of initial body weight and associated improvements in cardiometabolic and psychosocial indices. (Chao et al., 2022)

Improves Health

Suppress Appetite

     Decreases Body Fat

Semaglutide

Weight Loss Starts here!

We offer Compounded Semaglutide the same active ingredient found in Wegovy* and Ozempic*.

Pricing

Semaglutide Subcutaneous injections:

New Patient Protocol

$199.00/mo:   (0.25mg-1.0mg SQ once weekly)

Maintenance Protocol

$299.00/mo: (1.25mg-2.4mg SQ once weekly)

Semaglutide Sublingual Suspension:

New Patient Protocol

$299.00/mo (0.6mg-2.4mg PO twice weekly)

Maintenance Protocol

$429.00/monthly (3.6mg PO twice weekly)

Dosages are patient based and monitored by the licensed medical providers